BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 28966727)

  • 1. Identification of candidate genes associated with triple negative breast cancer.
    Player A; Abraham N; Burrell K; Bengone IO; Harris A; Nunez L; Willaims T; Kwende S; Walls W
    Genes Cancer; 2017 Jul; 8(7-8):659-672. PubMed ID: 28966727
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preliminary characterization of IL32 in basal-like/triple negative compared to other types of breast cell lines and tissues.
    Player A; Oguamanam T; Okanmelu J; Burrell K; Hollomon M
    BMC Res Notes; 2014 Aug; 7():501. PubMed ID: 25100201
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular Features of Triple Negative Breast Cancer: Microarray Evidence and Further Integrated Analysis.
    He J; Yang J; Chen W; Wu H; Yuan Z; Wang K; Li G; Sun J; Yu L
    PLoS One; 2015; 10(6):e0129842. PubMed ID: 26103053
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic utility and sensitivities of GATA3 antibodies in triple-negative breast cancer.
    Krings G; Nystrom M; Mehdi I; Vohra P; Chen YY
    Hum Pathol; 2014 Nov; 45(11):2225-32. PubMed ID: 25150746
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of Potential Key Genes Associated With the Pathogenesis, Metastasis, and Prognosis of Triple-Negative Breast Cancer on the Basis of Integrated Bioinformatics Analysis.
    Zhao B; Xu Y; Zhao Y; Shen S; Sun Q
    Front Oncol; 2020; 10():856. PubMed ID: 32596149
    [No Abstract]   [Full Text] [Related]  

  • 6. Integrated omics-based pathway analyses uncover CYP epoxygenase-associated networks as theranostic targets for metastatic triple negative breast cancer.
    Apaya MK; Shiau JY; Liao GS; Liang YJ; Chen CW; Yang HC; Chu CH; Yu JC; Shyur LF
    J Exp Clin Cancer Res; 2019 May; 38(1):187. PubMed ID: 31072371
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Classification of triple-negative breast cancers based on Immunogenomic profiling.
    He Y; Jiang Z; Chen C; Wang X
    J Exp Clin Cancer Res; 2018 Dec; 37(1):327. PubMed ID: 30594216
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum amyloid A predisposes inflammatory tumor microenvironment in triple negative breast cancer.
    Ignacio RMC; Gibbs CR; Kim S; Lee ES; Adunyah SE; Son DS
    Oncotarget; 2019 Jan; 10(4):511-526. PubMed ID: 30728901
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Guanylate-binding protein-1 is a potential new therapeutic target for triple-negative breast cancer.
    Quintero M; Adamoski D; Reis LMD; Ascenção CFR; Oliveira KRS; Gonçalves KA; Dias MM; Carazzolle MF; Dias SMG
    BMC Cancer; 2017 Nov; 17(1):727. PubMed ID: 29115931
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk stratification of triple-negative breast cancer with core gene signatures associated with chemoresponse and prognosis.
    Kim EK; Park AK; Ko E; Park WY; Lee KM; Noh DY; Han W
    Breast Cancer Res Treat; 2019 Nov; 178(1):185-197. PubMed ID: 31342312
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification by array comparative genomic hybridization of a new amplicon on chromosome 17q highly recurrent in BRCA1 mutated triple negative breast cancer.
    Toffoli S; Bar I; Abdel-Sater F; Delrée P; Hilbert P; Cavallin F; Moreau F; Van Criekinge W; Lacroix-Triki M; Campone M; Martin AL; Roché H; Machiels JP; Carrasco J; Canon JL
    Breast Cancer Res; 2014 Nov; 16(6):466. PubMed ID: 25416589
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cisplatin-resistant triple-negative breast cancer subtypes: multiple mechanisms of resistance.
    Hill DP; Harper A; Malcolm J; McAndrews MS; Mockus SM; Patterson SE; Reynolds T; Baker EJ; Bult CJ; Chesler EJ; Blake JA
    BMC Cancer; 2019 Nov; 19(1):1039. PubMed ID: 31684899
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential Regulation of Lacto-/Neolacto- Glycosphingolipid Biosynthesis Pathway Reveals Transcription Factors as Potential Candidates in Triple-Negative Breast Cancer.
    Zeng R; Mohamed A; Khanna KK; Hill MM
    Cancers (Basel); 2021 Jul; 13(13):. PubMed ID: 34283051
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chk1 as a new therapeutic target in triple-negative breast cancer.
    Albiges L; Goubar A; Scott V; Vicier C; Lefèbvre C; Alsafadi S; Commo F; Saghatchian M; Lazar V; Dessen P; Delaloge S; André F; Quidville V
    Breast; 2014 Jun; 23(3):250-8. PubMed ID: 24636978
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of differentially expressed genes between triple and non-triple-negative breast cancer using bioinformatics analysis.
    Zhai Q; Li H; Sun L; Yuan Y; Wang X
    Breast Cancer; 2019 Nov; 26(6):784-791. PubMed ID: 31197620
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Significantly increased PELP1 protein expression in primary and metastatic triple-negative breast carcinoma: comparison with GATA3 expression and PELP1's potential role in triple-negative breast carcinoma.
    Dang DN; Raj G; Sarode V; Molberg KH; Vadlamudi RK; Peng Y
    Hum Pathol; 2015 Dec; 46(12):1829-35. PubMed ID: 26428280
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chromosomal radiosensitivity of triple negative breast cancer patients.
    Francies FZ; Herd O; Cairns A; Nietz S; Murdoch M; Slabbert J; Claes KBM; Vral A; Baeyens A
    Int J Radiat Biol; 2019 Nov; 95(11):1507-1516. PubMed ID: 31348739
    [No Abstract]   [Full Text] [Related]  

  • 18. GSK3β regulates epithelial-mesenchymal transition and cancer stem cell properties in triple-negative breast cancer.
    Vijay GV; Zhao N; Den Hollander P; Toneff MJ; Joseph R; Pietila M; Taube JH; Sarkar TR; Ramirez-Pena E; Werden SJ; Shariati M; Gao R; Sobieski M; Stephan CC; Sphyris N; Miura N; Davies P; Chang JT; Soundararajan R; Rosen JM; Mani SA
    Breast Cancer Res; 2019 Mar; 21(1):37. PubMed ID: 30845991
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene Expression Profiling for Diagnosis of Triple-Negative Breast Cancer: A Multicenter, Retrospective Cohort Study.
    Wang Q; Xu M; Sun Y; Chen J; Chen C; Qian C; Chen Y; Cao L; Xu Q; Du X; Yang W
    Front Oncol; 2019; 9():354. PubMed ID: 31134153
    [No Abstract]   [Full Text] [Related]  

  • 20. Transcriptome analysis of Wnt3a-treated triple-negative breast cancer cells.
    Maubant S; Tesson B; Maire V; Ye M; Rigaill G; Gentien D; Cruzalegui F; Tucker GC; Roman-Roman S; Dubois T
    PLoS One; 2015; 10(4):e0122333. PubMed ID: 25848952
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.